Press Releases

McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care

McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer. Building on McKesson’s long history in community oncology, Ontada combines its real-world data and research capabilities with a leading suite of technologies for oncology clinicians, including the iKnowMed℠ electronic health record system and Clear Value Plus℠ regimen support tool, as well as a connection to a national community oncology network to transform the fight against cancer. Ontada’s...

McKesson Ventures Invests as Clinical Ink Debuts Lunexis™ ePRO+ Solution

Clinical Ink, a global clinical trial technology company, today announced an investment from McKesson Ventures, along with its significantly enhanced electronic patient reported outcome (ePRO) module. “McKesson Ventures is excited to invest in Clinical Ink, a market leader in clinical trial enablement technology,” said Dave Schulte, McKesson Ventures senior vice president and managing director. “Clinical Ink’s innovative eSource solutions are particularly well-positioned as the industry shifts to more decentralized trials and remote monitoring.” Lunexis™ ePRO+ is part of a unified technology platform that streamlines implementation processes and...

Michelle Snyder, Digital Health Veteran, Joins McKesson Ventures

McKesson Ventures has hired Michelle Snyder as its newest investment partner. Snyder, a mobile health pioneer, is known for her leadership and guidance in building Epocrates, one of the healthcare industry’s first successful mobile health companies. She brings more than 25 years of healthcare experience to the McKesson Ventures team and will support investments in healthcare technology and services companies. Snyder’s hire also expands the number of female partners at McKesson Ventures, underscoring the firm’s commitment to diversifying its leadership team. Prior to joining McKesson Ventures, Snyder...

Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience

Kyruus announced that Baptist Health, the largest nonprofit health system in Kentucky, has engaged the company to help elevate its digital access experience for consumers. The health system will collaborate with Kyruus to modernize the care search experience for consumers on the Baptist Health website and enable them to book appointments online. The Baptist Health team re-envisioned the online access experience for consumers, simplifying how they find the right care across the health system’s network and its more than 3,000 employed and affiliated physicians. To achieve...

IVX Health Completes Acquisition of Precision Healthcare

IVX Health, a national provider of infusion and injection therapy for patients with complex chronic conditions such as rheumatoid arthritis, multiple sclerosis, and Crohn’s disease, announced its acquisition of Precision Healthcare. Precision operates 12 infusion centers across Tennessee and northern Arkansas. The acquisition was led by a preferred equity investment from Linden Capital Partners and joined by existing institutional investors McKesson Ventures, Health Velocity Capital, and Nueterra Capital. For more than 20 years, Precision has cared for patients with autoimmune disorders and other conditions. The company employs...

Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition

Vineti, a leading digital platform of record for personalized therapeutics, announced the closing of a $33 million extension to its Series C financing round. The new financing will support further expansion of the company’s Personalized Therapy Management (PTM)® platform for personalized and high-value advanced therapies. The Series C extension is led by Cardinal Health, with participation from Marc Benioff and existing Vineti investors including McKesson Ventures, Novartis Pharma AG, LifeForce Capital, Threshold Ventures (formerly DFJ), Section 32, Casdin Capital, and other undisclosed entities. Eli Casdin, chief...

Augmedix Closes $25 Million Private Placement

Remote medical documentation and live clinical support services provider Augmedix has closed a $25 million private placement financing and completed a reverse merger with Malo Holdings Corp. “We’re thrilled to complete this financing, which we believe puts Augmedix on the path of accelerated expansion, and will enable us to broaden our operational capabilities, accelerate our technology research and product development, and strengthen our marketing and sales,” said the company’s Chief Executive Officer, Manny Krakaris. “The success of this financing demonstrates confidence in the Augmedix team, technology,...

Amwell Expands Partnership with Tyto Care to Extend Healthcare at Home

Amwell has expanded its partnership with Tyto Care, the healthcare industry’s first all-in-one modular device and examination platform for AI-powered, on-demand, remote medical exams. The two companies will introduce exclusive integrations and newly designed workflows and tools to enhance the ability for providers using the Amwell platform to examine and diagnose patients virtually. Amwell will also become a reseller of Tyto Care’s integrated devices. By pairing the TytoHome hand-held examination device—which enables on-demand examinations of the heart, lungs, abdomen, skin, throat, ears, heart rate, and body...

McKesson Ventures Grows Leadership Team with New Partner Promotions

McKesson Ventures has expanded its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners in the organization. Their promotions reflect McKesson Ventures’ commitment to an apprentice model of mentoring and promoting from within. Carter brings more than 20 years of healthcare experience, and her expertise spans marketing, business development, and sales operations. She joined McKesson Ventures in 2014 as vice president of portfolio development. In 2019, Carter expanded her role to oversee operations for the firm that include managing talent, budget, and resources. As...

Cleveland Clinic Joins Interventional Study Using GRAIL’s Multi-Cancer Early Detection Test to Help Guide Clinical Care

Cancer detection company GRAIL has announced that Cleveland Clinic has joined GRAIL’s PATHFINDER Study, a prospective, multi-cancer clinical study that is evaluating the implementation of Galleri™, an investigational multi-cancer early detection blood test, into clinical practice for the first time. Today, most cancers are found too late, when outcomes are often fatal, because most deadly cancers have no available screening tests. Current recommended screenings are critical, but they only cover four cancers and screen for a single cancer at a time. In fact, cancers responsible for...